7 Stocks' Revenue Totally Smashes All Expectations
It may be earnings season for the S&P 500 — but revenue is on top of many investors' minds. And some companies are showing top lines that top all views. Seven stocks in the S&P 500, including biotech Moderna, financial Northern Trust and miner Freeport-McMoRan, reported second-quarter revenue that topped expectations by 10% or more, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.